Synergy between LRH-1 and β-Catenin Induces G1 Cyclin-Mediated Cell Proliferation-Reference-Cited by-同舟云学术

Synergy between LRH-1 and β-Catenin Induces G1 Cyclin-Mediated Cell Proliferation

Published:2004-08 Issue:4 Volume:15 Page:499-509
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Botrugno Oronza A.,Fayard Elisabeth,Annicotte Jean-Sébastien,Haby Céline,Brennan Thomas,Wendling Olivia,Tanaka Toshiya,Kodama Tatsuhiko,Thomas Winston,Auwerx Johan,Schoonjans Kristina

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference48 articles.

1. Pancreatic-duodenal homeobox 1 regulates expression of liver receptor homolog 1 during pancreas development;Annicotte;Mol. Cell. Biol.,2003

2. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis;Arber;Gastroenterology,1996

3. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E;Bortner;Mol. Cell. Biol.,1997

4. The small heterodimer partner (SHP) interacts with the Liver X receptor alpha (LXRalpha) and represses its transcriptional activity;Brendel;Mol. Endocrinol.,2002

5. Liver receptor homologue-1 mediates species- and line-specific bile acid dependent negative feedback regulation of the apical sodium-dependent bile acid transporter;Chen;J. Biol. Chem.,2003

Cited by 253 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pioneer Transcription Factors: The First Domino in Zygotic Genome Activation;Biomolecules;2024-06-18

2. A reappraisal of transcriptional regulation by NR5A1 and beta-catenin in adrenocortical carcinoma;Frontiers in Endocrinology;2023-12-08

3. Liver receptor homolog-1 (NR5A2) orchestrates hepatic inflammation and TNF-induced cell death;Cell Reports;2023-12

4. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity;Journal of Experimental & Clinical Cancer Research;2023-11-28

5. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023;Pharmacological Reviews;2023-08-16